RxDoctor Payments Data

Sarah Hartz, MD

Psychiatry · Saint Louis, MONPI 1922216829

Payments from drug & device makers

$4,206in general payments, 2019–2025

Across 42 payments — averaging $100.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Neuronetics, Inc.$1K
  • Johnson & Johnson$285
  • AbbVie$219
  • Teva Pharmaceuticals USA, Inc.$168
  • Otsuka America Pharmaceutical, Inc.$98
  • plus $213 from 4 others

What the payments were for

  • Consulting fees$1,86044%
  • Travel & lodging$81919%
  • Food & beverage$1,52736%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,206 in reported general payments places this provider in the 80th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$14,972
Medicare patients
30
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate26$90,076
SpravatoEsketamine Hcl43$53,587
SuboxoneBuprenorphine Hcl/Naloxone Hcl20$10,774
BelsomraSuvorexant13$5,993
Aripiprazole30$5,388
Clozapine38$2,863
Paliperidone ErPaliperidone20$2,127
Divalproex Sodium ErDivalproex Sodium29$2,012
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine24$1,477
Duloxetine Hcl56$1,407
Olanzapine OdtOlanzapine17$1,378
Hydroxyzine Hcl37$1,356
Vilazodone Hcl13$1,174
Clonazepam171$1,166
Zolpidem Tartrate110$1,102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Spravato$285$143,66369 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →